KMDA
NASDAQ · Biotechnology
Kamada Ltd
$7.23
+0.09 (+1.26%)
Open$7.18
Previous Close$7.14
Day High$7.24
Day Low$7.16
52W High$9.35
52W Low$6.50
Volume—
Avg Volume48.0K
Market Cap417.13M
P/E Ratio20.48
EPS$0.35
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+301.4% upside
Current
$7.23
$7.23
Target
$29.02
$29.02
$25.25
$29.02 avg
$47.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 153.19M | 152.34M | 67.17M |
| Net Income | 19.97M | 17.88M | -1,989,318 |
| Profit Margin | 5.8% | 5.5% | -3.0% |
| EBITDA | 27.96M | 26.42M | -2,803,887 |
| Free Cash Flow | — | — | -2,727,774 |
| Rev Growth | +0.6% | +0.6% | +14.3% |
| Debt/Equity | 0.04 | 0.04 | 0.09 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |